These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 1673331
1. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms. Slovak ML, Coccia M, Meltzer PS, Trent JM. Anticancer Res; 1991; 11(1):423-8. PubMed ID: 1673331 [Abstract] [Full Text] [Related]
4. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG, Cole SP. Cancer Res; 1993 Jul 15; 53(14):3221-5. PubMed ID: 8391919 [Abstract] [Full Text] [Related]
12. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJ, Borst P. Cancer Res; 1990 Mar 15; 50(6):1779-85. PubMed ID: 1968359 [Abstract] [Full Text] [Related]
13. Genes amplified and overexpressed in human multidrug-resistant cell lines. Van der Bliek AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF, Hamilton TC, Joenje H, Borst P. Cancer Res; 1988 Nov 01; 48(21):5927-32. PubMed ID: 2901906 [Abstract] [Full Text] [Related]
14. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ. Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875 [Abstract] [Full Text] [Related]
15. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205 [Abstract] [Full Text] [Related]
16. Time course of MDR gene amplification during in vivo selection for doxorubicin-resistance and during reversal in murine leukemia L 1210. Volm M, Mattern J, Pommerenke EW. Anticancer Res; 1991 Nov 01; 11(2):579-85. PubMed ID: 1676579 [Abstract] [Full Text] [Related]
17. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line. Hill AB, Beck WT, Trent JM. Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436 [Abstract] [Full Text] [Related]
18. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations. Slovak ML, Hoeltge GA, Trent JM. Cancer Res; 1987 Dec 15; 47(24 Pt 1):6646-52. PubMed ID: 3677098 [Abstract] [Full Text] [Related]
19. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME. Cancer Res; 1987 Oct 01; 47(19):5141-8. PubMed ID: 2441861 [Abstract] [Full Text] [Related]
20. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region. Flahaut M, Mühlethaler-Mottet A, Martinet D, Fattet S, Bourloud KB, Auderset K, Meier R, Schmutz NB, Delattre O, Joseph JM, Gross N. Genes Chromosomes Cancer; 2006 May 01; 45(5):495-508. PubMed ID: 16450357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]